Dividends Calendar Earnings Calendar
NERV

NERV | Minerva Neurosciences Inc

Healthcare sector
Minerva Neurosciences Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Waltham, Massachusetts, United States

Trade prices

  • Volume: 62.3M
  • Market Cap: 19.17M
  • Prev closed: 2.29
  • Open: 2.22
  • High: 2.31
  • Low: 2.15
  • 52 week low: 1.81
  • 52 week high: 15.22
  • Dividends:No Dividends

Next ER: March 8, 2023  Before Market Opens



Top Stories (NERV)

    Company Profile

    Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of products to treat central nervous system (CNS) diseases. Minerva's portfolio of compounds includes: Roluperidone (MIN-101) in Phase 3 clinical  development for schizophrenia; a potential royalty stream from Seltorexant (MIN-202 or JNJ 42847922), in clinical development for insomnia and major depressive disorder (MDD); and MIN-301, in pre-clinical development for Parkinson's disease. Minerva's common stock is listed on the NASDAQ Global Market under the symbol "NERV."

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    May 8, 2023
    March 8, 2023-1.26 / -1.01- / -
    November 9, 2022-1.29 / -1.38- / -
    August 9, 2022-1.63 / -1.66- / -
    May 9, 2022- / -0.1719- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 15, 2022 3.110 3.100
    3.320
    3.060
    		 282.31K -5.47%
    Aug 12, 2022 3.290 3.380
    3.600
    3.110
    		 296.19K -2.95%
    Aug 11, 2022 3.390 3.400
    3.400
    3.150
    		 193.21K -0.88%
    Aug 10, 2022 3.420 3.740
    3.740
    3.290
    		 337.84K -5%
    Aug 9, 2022 3.600 4.380
    4.540
    3.600
    		 510.29K -23.89%
    Aug 8, 2022 4.730 4.780
    5.040
    4.580
    		 584.17K -4.44%
    Aug 5, 2022 4.950 3.860
    5.360
    3.820
    		 2.05M 5.32%
    Aug 4, 2022 4.700 3.020
    7.150
    2.850
    		 37.62M 75.37%
    Aug 3, 2022 2.680 2.765
    2.765
    2.620
    		 52.55K 0%
    Aug 2, 2022 2.680 2.540
    2.790
    2.540
    		 35.82K 3.88%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2007
    • Employees:11

    News

    News for (NERV)

    This company doesn't provide a dividend.


    Talk about Minerva Neurosciences Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Mar 8, 2023 (Same day)

    clls cpb unfi abm mdb fosl asan vra ndls best ampe trvn 


    Jump to (Finance sites)

    Google   
             

    Research 


    Investor page

    ir.minervaneurosciences.com

    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    LinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis